CClinicalTrials.gg
Status unknownNCT00573196Updated Aug 17, 2009

Far Infrared Radiation Treatment for Bipolar Condition

A Phase 1 interventional study of Far infrared in Bipolar Disorder, sponsored by GAAD Medical Research Institute Inc.. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2009-08-17.

Sponsored by GAAD Medical Research Institute Inc. · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2009), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
3
Allocation
Randomized
Sex
All
01

Study summary

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

Read the detailed description

A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant \& entrepreneur Ted Turner, excelled in life due to the additional brain power!

The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

02

Conditions studied

  • Bipolar Disorder

Browse trials for

Keywords

  • Affective Psychosis, Bipolar
  • Depression, Bipolar
  • Mania
  • Manic Disorder
  • Manic State
  • Manic-Depressive Psychosis
  • Psychoses, Manic-Depressive
  • Psychosis, Manic-Depressive
03

In context

Bipolar Disorder

1,601 studies on the registry are indexed under Bipolar Disorder; 254 are open to participants now.

This study's enrollment of 3 is below the median of 64 across 1,223 interventional studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

GAAD Medical Research Institute Inc. is the lead sponsor of 21 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia

Exclusion criteria

Exclusion Criteria:

  • Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    1

    Radiation: Far infrared

Interventions

  • RadiationFar infrared

    Far infrared radiation (5μm to 15μm wavelength)

06

What researchers measure

Primary outcomes

  1. The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.

    Time frame: 2 years

Secondary outcomes

  1. The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.

    Time frame: 2 years

07

Study locations

1 site
  • The Centre for Incurable Diseases
    Mississauga, Ontario L5R 3G9, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00573196
Lead sponsor
GAAD Medical Research Institute Inc.
First posted
Dec 14, 2007
Start date
Sep 2006
Primary completion
Feb 2008
Completion
Jun 2008 (estimated)
Last update
Aug 17, 2009

Study contacts

Kwasi Donyina, Ph.D.
principal investigator · GAAD Medical Research Institute Inc.
Ken Nedd, M.D.
study director · GAAD Medical Research Institute Inc.

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion